1.Thymic carcinoma involving sternum: a case report.
Chuan-liang PENG ; Xiao-gang ZHAO ; Dong-mei ZHAO ; Xiao-peng DONG
Chinese Medical Journal 2008;121(5):478-479
2.Mixed multilocular ectopic thymic cyst with parathyroid element presenting as neck mass.
Pathak GAYATRI ; Deshmukh SANJAY ; Naik AJAY ; Ashturkar AMRUT
Annals of the Academy of Medicine, Singapore 2012;41(6):271-272
Child
;
Female
;
Head and Neck Neoplasms
;
diagnosis
;
pathology
;
surgery
;
Humans
;
Parathyroid Neoplasms
;
diagnosis
;
pathology
;
surgery
;
Thymus Gland
;
pathology
;
surgery
;
Thymus Neoplasms
;
diagnosis
;
pathology
;
surgery
3.Minimally Invasive Surgery in Thymic Malignances.
Wentao FANG ; Zhitao GU ; Keneng CHEN ; Members of the Chinese Alliance for Research in Thymomas
Chinese Journal of Lung Cancer 2018;21(4):269-272
Surgery is the most important therapy for thymic malignances. The last decade has seen increasing adoption of minimally invasive surgery (MIS) for thymectomy. MIS for early stage thymoma patients has been shown to yield similar oncological results while being helpful in minimize surgical trauma, improving postoperative recovery, and reduce incisional pain. Meanwhile, With the advance in surgical techniques, the patients with locally advanced thymic tumors, preoperative induction therapies or recurrent diseases, may also benefit from MIS in selected cases.
Humans
;
Minimally Invasive Surgical Procedures
;
methods
;
trends
;
Retrospective Studies
;
Thymoma
;
surgery
;
Thymus Neoplasms
;
mortality
;
pathology
;
surgery
4.Thymic carcinoid: report of a case.
Chinese Journal of Pathology 2010;39(9):638-639
Carcinoid Tumor
;
metabolism
;
pathology
;
surgery
;
Female
;
Humans
;
Middle Aged
;
Phosphopyruvate Hydratase
;
metabolism
;
Synaptophysin
;
metabolism
;
Thymectomy
;
Thymus Neoplasms
;
metabolism
;
pathology
;
surgery
6.Surgical therapy of thymic cancer.
Zi-Yong ZHANG ; Tao CHEN ; Yu-shang CUI ; Shan-qing LI ; Li LI ; Xiao-hui XU ; Feng GUO
Chinese Journal of Oncology 2005;27(12):759-759
Adult
;
Aged
;
Carcinoma, Small Cell
;
pathology
;
surgery
;
Carcinoma, Squamous Cell
;
pathology
;
surgery
;
Female
;
Humans
;
Male
;
Middle Aged
;
Thymus Neoplasms
;
pathology
;
surgery
7.Thymoma with Pseudosarcomatous Stroma.
Tae Woong NOH ; Se Hoon KIM ; Beom Jin LIM ; Woo Ick YANG ; Kyung Young CHUNG
Yonsei Medical Journal 2001;42(5):571-575
Thymoma with psuedosarcomatous stroma is a recently described, rare variant of thymomas that are characterized by having a biphasic histologic pattern which consists of both an epithelial and a spindle cell stromal component. So far only 11 cases having similar histologic findings have been reported world wide. At this time we report a case of this rare variant of thymoma which occurred in a 53-year-old Korean man. This previously healthy patient presented with coughing and an anterior mediastinal mass was then detected radiographically. Mediastinal exploration revealed a 9 x 8 x 8 cm-sized well- encapsulated, ovoid, cystic mass. Histological examination showed a biphasic neoplasm composed of anastomosing nests of epithelial cells and somewhat cellular stromal spindle cells that had advanced degenerative changes. Immunohistochemical staining using the antibodies for cytokeratins, EMA, e-cadherin, and p75NGFR showed a strong expression of these markers in the epithelial component but no expression in the spindle stromal cells. The epithelial tumor cells showed no reactivity to CD5 and L26 and a high proportion of the infiltrated lymphocytes were the cortical type that expressed CD99 and terminal deoxynucleotidyl transferase. Ultrastructural examinations revealed tonofilaments in the spindle cells. Follow up has been done for 5 years after the surgical excision and the patient has been free of disease during that period. Similar to previous reports, this patient had a benign clinical course that was unassociated with myasthenia gravis which appears to be a characteristic of this histologic variant of thymoma. However, our case also showed advanced degenerative features and we could demonstrate ultrastructural evidence of epithelial differentiation in the stromal spindle cells that were not mentioned in the previously reported cases. Based on the results of our studies, we suggest this entity is a distinct type of organotypic thymoma that shows cortical differentiation and abundant cellular stroma.
Case Report
;
Human
;
Immunohistochemistry
;
Male
;
Microscopy, Electron
;
Middle Age
;
Sarcoma/*pathology
;
Stromal Cells/*pathology
;
Thymoma/*pathology/surgery
;
Thymus Neoplasms/*pathology/surgery
8.Thymoma associated with an lipofibroadenoma: report of a case.
Yan-li WANG ; Xiang-hua YI ; Gang CHEN ; Chun-yan WU
Chinese Journal of Pathology 2009;38(8):556-557
Diagnosis, Differential
;
Fibroadenoma
;
metabolism
;
pathology
;
surgery
;
Humans
;
Keratins
;
metabolism
;
Lipoma
;
metabolism
;
pathology
;
surgery
;
Male
;
Middle Aged
;
Mucin-1
;
metabolism
;
Neoplasms, Multiple Primary
;
metabolism
;
pathology
;
surgery
;
Thymoma
;
metabolism
;
pathology
;
surgery
;
Thymus Neoplasms
;
metabolism
;
pathology
;
surgery
;
Vimentin
;
metabolism
9.Metastatic Thymoma of the Breast.
Sung Mok KIM ; Eun Young KO ; Boo Kyung HAN ; Jung Hee SHIN ; Seok Seon KANG ; Seok Jin NAM ; Eun Yoon CHO
Korean Journal of Radiology 2008;9(1):80-83
Breast metastasis from nonmammary malignant neoplasms is uncommon, and it accounts for approximately 2% of all breast tumors. Distant metastasis of thymoma is very rare, and especially to extrathorcic areas. We report a female who had a metastatic thymoma in her breast 20 years after undergoing resection for a non-invasive thymoma. She presented with a palpable mass in her left breast. Mammography and ultrasonogram showed a lobular mass at the anterior glandular portion. Histological examination after surgical excision revealed a metastatic thymoma.
Breast Neoplasms/diagnosis/*secondary/surgery
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Middle Aged
;
Thymoma/diagnosis/*secondary/surgery
;
Thymus Neoplasms/diagnosis/*pathology/surgery
;
Tomography, X-Ray Computed
;
Ultrasonography, Mammary
10.The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis.
Yunfeng ZHANG ; Lei YU ; Yun JING ; Ji KE
Chinese Journal of Surgery 2015;53(8):612-616
OBJECTIVETo evaluate the different pathological and clinical characteristics of thymomas with and without myasthenia gravis (MG) and to determine whether the presence of MG influences the prognosis in thymoma patients.
METHODSThe clinical data from 228 consecutive patients (median sternotomy were used in 153, video-assisted thoracoscopic themectomy were used in 75) operated on from January 1992 to December 2007 was analyzed retrospectively. These thymoma patients had been subdivided into two groups: thymoma with MG (n = 125) and thymoma without MG (n = 103). All thymic epithelial tumors were classified according to the WHO histologic classification and the Masaoka clinical staging system. The result was evaluated according to the Myasthenia Gravis Foundation of America's criterion. The clinical features of the 2 test was compared between the two groups by χ² test, and the survival were compared between the two groups by Cox analysis.
RESULTSThere were no peri-operative deaths. 19 cases were inoperable (6 in the group with MG, 13 without MG (χ² = 4.52, P = 0.035)). The proportions of type A and thymic carcinoma were 0 in the group with MG, 10.5% (11/103) and 11.6% (12/103) respectively in the group without MG. According to the Masaoka's clinical staging, in the group MG, 24.8% (31/125) patients were stage III and IV; in the group without MG, 33.0% (34/103) patients were stage III and IV. There was a significant difference between hyperplastic paraneoplastic thymus coexisting in 28.8% (36/125) patients with MG and only 5.8% (6/103) in patients without MG (χ² = 20.91, P = 0.000) Microthymoma was identified in the paraneoplastic thymus of 3 patients with MG. There were 198 patients followed up, the rate was 86.8% (198/228). There was no recurrence in patients with type A and a few patients with type AB, B1, B2, B3 thymoma and thymic carcinoma recurred. The actuarial 5- and 10-year survival rates were 89.3% and 81.2% for patients with MG respectively, and 90.0% and 78.9% for patients without MG respectively. Within 5 years postoperatively, 6 of 9 patients with MG died of myasthenia crisis, while 6 out of 7 deaths in patients without MG were attributable to inoperable tumors (stage IV) and thymic carcinoma.
CONCLUSIONSThe existence of myasthenia gravis has little influence on the prognosis of thymomas, but it is good for early diagnosis and treatment. Extended thymectomy should be performed to all patients with thymoma, no matter they have myasthenia gravis or not. The main cause of death is myasthenia crisis for thymoma patients with MG and stage IV and (or) thymic carcinoma for patients without MG.
Humans ; Myasthenia Gravis ; complications ; pathology ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Neoplasms, Glandular and Epithelial ; complications ; pathology ; surgery ; Postoperative Period ; Prognosis ; Retrospective Studies ; Sternotomy ; Survival Rate ; Thoracic Surgery, Video-Assisted ; Thymectomy ; Thymoma ; complications ; pathology ; surgery ; Thymus Neoplasms ; complications ; pathology ; surgery